NAMENDA XR
Live / Registered — Registered and renewed (as of 16 Jan 2024)
What this means for you
Registered since 08 Oct 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Oct 2023).
Record
- Serial number
- 85642435
- Registration number
- 4415656
- Mark type
- Stylized text
- Filed
- 04 Jun 2012
- Published for opposition
- 21 May 2013
- Registered
- 08 Oct 2013
- Next maintenance due
- 08 Oct 2023
- Attorney of record
- G. Patrick SAGE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cerebral and neurologic disorders, diseases and conditions
Owner
- MERZ PHARMA GmbH & CO. KGaA, FRANKFURT am MAIN, DE
- MERZ PHARMA GmbH & CO. KGaA, FRANKFURT am MAIN, DE
- MERZ PHARMA GmbH & CO. KGaA, FRANKFURT am MAIN, DE
Prior registrations
Prosecution history
- 16 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Jan 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Jan 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jul 2023 — TEAS SECTION 8 & 9 RECEIVED
- 08 Oct 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Oct 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Oct 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Oct 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Sept 2019 — TEAS SECTION 8 & 15 RECEIVED
- 08 Oct 2013 — REGISTERED-PRINCIPAL REGISTER
- 06 Sept 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 05 Sept 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 03 Sept 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Aug 2013 — STATEMENT OF USE PROCESSING COMPLETE